Quote:It will undoubtedly move higher just on excitement. I think it will be followed by a pullback when investors dwell on what the FDA does next and the timeline to approval. Of course a buyout offer, approval on phase 2 (doubtful without further data) or something else unexpected may occur.
What about a possibility of a BTD? I notice recent discussions don’t mention this path.
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.